http://www.rxpgnews.com/ Medical News and Information Thu, 21 Aug 2008 02:00:28 PST en-us http://www.rxpgnews.com/lanthanum/Higher_Initial_Doses_of_FOSRENOL_Result_in_More_Ra_4130_4130.shtml Lanthanum According to data presented today at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication. Sun, 23 Apr 2006 19:11:00 PST http://www.rxpgnews.com/lanthanum/Higher_Initial_Doses_of_FOSRENOL_Result_in_More_Ra_4130_4130.shtml